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Background: Redo surgical mitral valve repair carries a high perioperative risk in the presence of severely reduced ventricular function and/
or relevant comorbidities. We sought to assess the feasibility of catheter-based mitral valve repair using the MitraClip system in patients in whom 
previous surgical annuloplasty failed to maintain initial mitral regurgitation (MR) reduction.
methods: Since starting the MitraClip program at our center in 9/2008, a total of 6 patients (age 75±12 years [range: 59-90 years]) with 
recurrence of symptomatic MR grade ≥3 following prior surgical mitral annuloplasty underwent MitraClip therapy. Time interval between mitral 
valve surgery and interventional procedure was 3.6±4.0 years (range: 0.8-9.0 years). Risk for redo surgery was considered high by means of logistic 
EuroScore II of 24.5±6.1 % and STS score of 18.7±8.3 %, respectively.
results: MitraClip implantation was successful in 4 of 6 patients. In these patients, procedure-related reduction in MR severity was three grades 
in one patient, two grades in two patients, and one grade in 1 patient. As a consequence, NYHA functional status improved from 4 to 2 in 2 patients 
and from 3 to 2 in the other 2 patients, respectively. One of the patients with failed MitraClip therapy underwent surgical valve repair. At 6-month 
follow-up, all 6 patients continued to be alive.
conclusion: Mitral valve repair using the MitraClip system for recurrence of MR following prior surgical annuloplasty may represent a therapeutic 
option in a subgroup of symptomatic patients carrying a high-risk for redo surgery.
